<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="abstract"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Eur Psychiatry</journal-id><journal-id journal-id-type="iso-abbrev">Eur Psychiatry</journal-id><journal-id journal-id-type="publisher-id">EPA</journal-id><journal-title-group><journal-title>European Psychiatry</journal-title></journal-title-group><issn pub-type="ppub">0924-9338</issn><issn pub-type="epub">1778-3585</issn><publisher><publisher-name>Cambridge University Press</publisher-name><publisher-loc>Cambridge, UK</publisher-loc></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmc">PMC11862071</article-id><article-id pub-id-type="doi">10.1192/j.eurpsy.2024.294</article-id><article-id pub-id-type="other">EPP0062</article-id><article-id pub-id-type="pii">S0924933824002943</article-id><article-categories><subj-group subj-group-type="heading"><subject>Abstract</subject></subj-group><subj-group subj-group-type="section"><subject>e-Poster Presentation</subject></subj-group></article-categories><title-group><article-title>Relevance of measurement of b&#x000ea;ta-2-microglobulin in schizophrenia</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name><surname>Aissa</surname><given-names>A.</given-names></name><xref rid="aff0563" ref-type="aff">
<sup>1</sup></xref><xref rid="aff0564" ref-type="aff">
<sup>2</sup></xref><xref rid="cor0155" ref-type="corresp">
<sup>*</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Arij</surname><given-names>A. B. C.</given-names></name><xref rid="aff0565" ref-type="aff">
<sup>3</sup></xref></contrib><contrib contrib-type="author"><name><surname>Jedda</surname><given-names>S.</given-names></name><xref rid="aff0563" ref-type="aff">
<sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Askri</surname><given-names>F.</given-names></name><xref rid="aff0563" ref-type="aff">
<sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Jomli</surname><given-names>R.</given-names></name><xref rid="aff0563" ref-type="aff">
<sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Abaza</surname><given-names>H.</given-names></name><xref rid="aff0566" ref-type="aff">
<sup>4</sup></xref></contrib></contrib-group><aff id="aff0563">
<sup>1</sup>Psychiatry A, <institution>Razi Hospital</institution>, <city>Manouba</city></aff><aff id="aff0564">
<sup>2</sup>Psychiatry, <institution>Faculty of Medicine of Tunis</institution></aff><aff id="aff0565">
<sup>3</sup>Human genetic lab, <institution>Salah Azaiez Institute</institution>, <city>Tunis</city></aff><aff id="aff0566">
<sup>4</sup>Clinical biology, <institution>Razi Hospital</institution>, <city>Manouba</city>, <country>Tunisia</country></aff><author-notes><corresp id="cor0155"><label>*</label>Corresponding author.</corresp></author-notes><pub-date publication-format="electronic" date-type="collection" iso-8601-date="2024-04"><month>4</month><year>2024</year></pub-date><pub-date pub-type="epub"><day>27</day><month>8</month><year>2024</year></pub-date><volume>67</volume><issue seq="269">Suppl 1</issue><issue-title content-type="special_issue">Abstracts of the 32nd European Congress of Psychiatry</issue-title><fpage>S125</fpage><lpage>S126</lpage><permissions><copyright-statement>&#x000a9; The Author(s) 2024</copyright-statement><copyright-year>2024</copyright-year><copyright-holder>The Author(s)</copyright-holder><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (<uri xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</uri>), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><self-uri xlink:title="pdf" xlink:href="S0924933824002943a.pdf"/><abstract><sec id="sec0930"><title>Introduction</title><p>There are several arguments supporting the inflammatory hypothesis in schizophrenia (SCZ). Among the inflammatory markers, beta-2- microglobulin (&#x003b2;2M) is associated with abnormalities in neurogenesis and cognitive impairment described in (SCZ).</p></sec><sec id="sec0931"><title>Objectives</title><p>The objectives of our study were to evaluate the level of &#x003b2;2M in a group of patients compared with a control group and to investigate the sociodemographic, clinical, and environmental factors associated with elevated &#x003b2;2M levels</p></sec><sec id="sec0932"><title>Methods</title><p>We conducted a cross-sectional in outpatients with SCZ. We collected patients sociodemographic, environmental, and clinical data. We assessed psychopathology with the PANSS. We measured serum &#x003b2;2M concentration.</p></sec><sec id="sec0933"><title>Results</title><p>We included 30 patients with SCZ compared with 20 controls. Patients mean age was 40,23&#x000b1;10,66. The mean level of &#x003b2;2M was 1,98 &#x000b1; 0.42 mg/L for patients and 1.65&#x000b1;0.56 mg/L for control group. The difference was significant between the patient group and the control group (p&#x00026;lt;10-3). No environmental or clinical factors have been associated with &#x003b2;2M levels other than smoking status (p=0.046).</p></sec><sec id="sec0934"><title>Conclusions</title><p>Further research with larger samples investigating the different stages of SCZ especially early psychosis would be needed to confirm the relevance of this biomarker in SCZ.</p></sec><sec id="sec0935"><title>Disclosure of Interest</title><p>None Declared</p></sec></abstract><counts><page-count count="2"/></counts></article-meta></front></article>